Literature DB >> 8099016

The NH2-terminal domain of rat CD2 binds rat CD48 with a low affinity and binding does not require glycosylation of CD2.

P A van der Merwe1, D C McPherson, M H Brown, A N Barclay, J G Cyster, A F Williams, S J Davis.   

Abstract

CD2, CD48 and CD58 are structurally similar cell adhesion-molecules forming a subset of the immunoglobulin superfamily (IgSF). In humans CD58 is a ligand for CD2 while in mice CD2 binds CD48. We constructed a soluble chimeric molecule comprising the extracellular portion of rat CD48 and domains 3 and 4 of rat CD4 (sCD48-CD4) and used it to examine whether CD2 is a ligand for CD48 in rats. sCD48-CD4-coated polystyrene Dynabeads formed rosettes on rat CD2-transfected COS-7 cells, and this rosetting was blocked by anti-CD2 (OX34) and anti-CD48 (OX45) monoclonal antibodies. We used sucrose-gradient ultracentrifugation to show that sCD48-CD4 binds, in solution, to soluble forms of rat CD2 including the single NH2-terminal IgSF domain of rat CD2 expressed in bacteria. The upper limit of the affinity of the rat CD48-CD2 interaction is 4 x 10(5) M-1, lower than the published affinity of human CD2 for CD58. These results show that rat CD48 binds CD2 on its NH2-terminal IgSF domain with a low affinity and that binding is independent of glycosylation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099016     DOI: 10.1002/eji.1830230628

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

1.  One sequence, two folds: a metastable structure of CD2.

Authors:  A J Murray; S J Lewis; A N Barclay; R L Brady
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

2.  Initiation and perpetuation of rat adjuvant arthritis is inhibited by the anti-CD2 monoclonal antibody (mAb) OX34.

Authors:  J C Hoffmann; C Herklotz; H Zeidler; B Bayer; H Rosenthal; J Westermann
Journal:  Ann Rheum Dis       Date:  1997-12       Impact factor: 19.103

3.  The CD58 (LFA-3) binding site is a localized and highly charged surface area on the AGFCC'C" face of the human CD2 adhesion domain.

Authors:  A R Arulanandam; J M Withka; D F Wyss; G Wagner; A Kister; P Pallai; M A Recny; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

4.  CD48-deficient mice have a pronounced defect in CD4(+) T cell activation.

Authors:  J González-Cabrero; C J Wise; Y Latchman; G J Freeman; A H Sharpe; H Reiser
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

5.  Cattle CTLA-4, CD28 and chicken CD28 bind CD86: MYPPPY is not conserved in cattle CD28.

Authors:  K R Parsons; J R Young; B A Collins; C J Howard
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

6.  Homotypic adhesion of rat B cells, but not T cells, in response to cross-linking of CD48.

Authors:  D Garnett; A F Williams
Journal:  Immunology       Date:  1994-01       Impact factor: 7.397

7.  Advances in animal cell recombinant protein production: GS-NS0 expression system.

Authors:  L M Barnes; C M Bentley; A J Dickson
Journal:  Cytotechnology       Date:  2000-02       Impact factor: 2.058

Review 8.  CD58 Immunobiology at a Glance.

Authors:  Yalu Zhang; Qiaofei Liu; Sen Yang; Quan Liao
Journal:  Front Immunol       Date:  2021-06-08       Impact factor: 7.561

9.  2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48.

Authors:  M H Brown; K Boles; P A van der Merwe; V Kumar; P A Mathew; A N Barclay
Journal:  J Exp Med       Date:  1998-12-07       Impact factor: 14.307

10.  Amino acid residues required for binding of lymphocyte function-associated antigen 3 (CD58) to its counter-receptor CD2.

Authors:  L Osborn; E S Day; G T Miller; M Karpusas; R Tizard; S C Meuer; P S Hochman
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.